�onofi

23rd February 2022

The Secretary

The Secretary

Bombay Stock Exchange Limited

The National Stock Exchange of India Limited

Phiroze Jeejeebhoy Towers

Exchange Plaza, 5th Floor

Dalal Street

Plot No. C/1, G Block

Mumbai 400 001

Bandra-Kurla Complex

Sandra East

Mumbai 400 050

Audited Financial Results for the year ended 31 st December 2021

Dear Sirs,

We refer to our letter dated 7th February 2022 informing you of our Board Meeting that was scheduled today. The meeting of Board of Directors commenced at 2.30 p.m. and concluded at 6.15 p.m. The Board approved audited financial results for the quarter and year ended 31st December 2021.

We enclose a copy of the auditor's report and audited financial results of the Company for the quarter and year ended 31st December 2021 along with statement of assets and liabilities as on that date and statement of cashflows for the year ended 31st December 2021 along with press release as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for your information.

Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company, M/s Price Waterhouse & Co. Chartered Accountants LLP have issued the Audit Report with unmodified opinion for the financial year ended 31st December 2021.

Please take the above information on record.

Thanking you,

Yours faithfully

For Sanofi India Limited

Radhika Shah

Company Secretary &Compliance Officer

Membership No.: 19308

Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939

Corporate Identity Number: L24239MH1956PLC009794

Website: www.sanofiindialtd.com I www.sanofi.in

Email: igrc.sil@sanofi.com

SANOFI INDIA LIMITED

Registered Office : Sanofi House,C.T.S No - 117-8, L & T Business Park, Saki Vihar Road, Powai, Mumbai 400 072.

Corporate Identity Number: L24239MH1956PLC009794

Tel no: (91-22) 28032000

Fax No: (91-22) 28032846

Website: www.sanofiindialtd.com

Email: igrc.sil@sanofi.com

STATEMENT OF AUDITED FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021

Quarter

Quarter

Quarter

Year

Particulars

ended

ended

ended

ended

31.12.2021

30.09.2021

31.12.2020

31.12.2021

(Audited)

(Audited)

Refer Note 7

(Unaudited)

Refer Note 7

(Audited)

1. Revenue from Operations

6,879

7,545

7,203

29,566

2. Other Income

163

147

162

744

3. Total Income (1+2)

7,042

7,692

7,365

30,310

4. Expenses

(a) Cost of Materials Consumed

1,288

1,456

1,483

5,551

(b) Purchases of stock in trade

1,670

1,996

1,609

7,086

(c) Olanges in Inventories of finished goods, work-in-progress and stock-in-trade

126

(130)

68

431

(d) Employee benefits expense

1,082

1,074

1,072

4,339

(e) Finance costs

4

5

4

18

(f) Depreciation and amortisation expense

109

143

204

667

(g) Other expenses

1,441

1,161

1,301

4,534

Total Expenses

5,720

5,705

5,741

22,626

5. Profit before exceptional item and tax (3-4)

1,322

1,987

1,624

7,684

6. Exceptional item (Refer notes 4 & 5)

-

4,892

78

4,892

7. Profit before tax (5+6)

1,322

6,879

1,702

12,576

8. Tax expense

Current Tax

430

1,714

467

3,360

Deferred Tax

(12)

(133)

5

(228)

9. Profit for the year/period (7-8)

904

5,298

1,230

9,444

10. Other comprehensive income (00) (Net of Tax)

(33)

-

(51)

(33)

11. Total comprehensive income for the year/period (9+10)

871

5,298

1,179

9,411

12. Paid-up equity share capital (Face Value of� 10 per share)

230

230

230

230

13. Other equity

-

-

-

22,026

14. Basic and diluted earnings per share (not annualised)

39.25

230.04

53.41

410.06

  • in Million
    Year

ended

31.12.2020

(Audited)

29,019

898

29,917

5,914

6,047

575

4,608

18

822

4,744

22,728

7,189

(417)

6,772

2,110

(114)

4,776

(88)

4,688

230

20,960

207.38

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Sanofi India Ltd. published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 11:12:31 UTC.